Hyperthyroidism influences ultrasound bone measurement on the Os calcis

被引:27
作者
Acotto, CG [1 ]
Schott, AM
Hans, D
Niepomniszcze, H
Mautalen, CA
Meunier, PJ
机构
[1] Hosp Clin Jose San Martin, Secc Osteopatias Med, Div Endocrinol, RA-23511120 Buenos Aires, DF, Argentina
[2] Hosp Clin Jose San Martin, Secc tiroides, Div Endocrinol, RA-23511120 Buenos Aires, DF, Argentina
[3] Hop Edouard Herriot, Unite 403, Lyon, France
关键词
BMD; bone loss; hyperthyroidism; ultrasound parameters;
D O I
10.1007/s001980050091
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The objective of our study was to compare bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA) and quantitative ultrasound (QUS) parameters in women with hyperthyroidism and controls. In this cross-sectional study, QUS parameters and BMD values observed in untreated hyperthyroid patients were compared with data obtained from age-matched controls. Twenty-four women with Graves' disease were studied. Eight patients were postmenopausal. All patients had evidence of thyrotoxicosis as indicated by a raised total serum thyroxine and a suppressed serum thyroid stimulating hormone. BMD of the hip, lumbar spine and whole body, and body composition, were measured by DXA. Ultrasound evaluation on the os calcis was performed with an Achilles device. All measurements were performed before antithyroid therapy. The QUS parameters of BUA, SOS and Stiffness were significantly lower in hyperthyroid patients than in controls. Similar results were observed for the BMD of lumbar spine, femoral neck and total skeleton. Lean tissue and fat mass were also significantly decreased in hyperthyroid patients. In conclusion, these findings suggest that hyperthyroidism affects cortical and trabecular bone equally, as well as bone quality. QUS measurements may be helpful for assessing, using a simple and non-irradiating method, the bone effects of thyrotoxicosis.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 29 条
[1]
DISCRIMINATION OF TOTAL-BODY BONE-MINERAL DENSITY MEASURED BY DEXA IN VERTEBRAL OSTEOPOROSIS [J].
BAGUR, A ;
VEGA, E ;
MAUTALEN, C .
CALCIFIED TISSUE INTERNATIONAL, 1995, 56 (04) :263-267
[2]
BAUER DC, 1995, J BONE MINER RES, V10, pS470
[3]
BAYLEY TA, 1980, J CLIN ENDOCR METAB, V50, P916, DOI 10.1210/jcem-50-5-916
[4]
BIANCHI GS, 1972, ORTHOP CLIN N AM, V3, P745
[5]
BONE MASS IN FEMALES WITH DIFFERENT THYROID-DISORDERS - INFLUENCE OF MENOPAUSAL STATUS [J].
CAMPOSPASTOR, MM ;
MUNOZTORRES, M ;
ESCOBARJIMENEZ, F ;
DEALMODOVAR, MR ;
GIMENO, EJ .
BONE AND MINERAL, 1993, 21 (01) :1-8
[6]
RISK-FACTORS FOR HIP FRACTURE IN WHITE WOMEN [J].
CUMMINGS, SR ;
NEVITT, MC ;
BROWNER, WS ;
STONE, K ;
FOX, KM ;
ENSRUD, KE ;
CAULEY, JC ;
BLACK, D ;
VOGT, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (12) :767-773
[7]
THYROTOXIC BONE-DISEASE IN WOMEN - A POTENTIALLY REVERSIBLE DISORDER [J].
DIAMOND, T ;
VINE, J ;
SMART, R ;
BUTLER, P .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (01) :8-11
[8]
TRABECULAR BONE REMODELING AND BONE BALANCE IN HYPERTHYROIDISM [J].
ERIKSEN, EF ;
MOSEKILDE, L ;
MELSEN, F .
BONE, 1985, 6 (06) :421-428
[9]
ERIKSEN EF, 1986, ENDOCR REV, V7, P4
[10]
FRASER S, 1971, LANCET, V15, P981